Concentra Group Holdings Parent, Inc. (CON)

Concentra announced its Q4 and full-year 2025 results, reporting revenue and net income increases. The company released preliminary 2025 financial results and provided 2026 guidance, exceeding previous expectations. A fourth-quarter dividend of US$0.063 was announced. Concentra authorized a share repurchase program and repurchased approximately 1.1 million shares. The company expanded its footprint through new medical center additions and the acquisition of Nova Medical Centers. New members with experience in data, technology, digital transformation, and healthcare were appointed to its Board of Directors.

The demand for Concentra's occupational health services is generally higher during the summer months. The company's revenue can fluctuate based on the number of business days within each calendar quarter. This seasonality is linked to an uptick in heat-related illnesses and overexertion injuries during warmer months, as well as increased physical demands from seasonal work. Winter months can bring different occupational health challenges such as cold and flu season, and risks associated with icy conditions.

Concentra Group Holdings Parent, Inc. operates in the healthcare sector, focusing on medical care facilities and occupational health services, with a mission to improve the health of America's workforce. Its services include work injury care, physical therapy, drug and alcohol testing, DOT physical exams, employer services, onsite health clinics, telemedicine, Concentra Pharmacy, and Concentra Medical Compliance Administration.

Concentra operates across 47 states and the District of Columbia, with 628 occupational health centers and 411 onsite health clinics as of December 31, 2025. The company expanded its presence through acquisitions, including Nova Medical Centers in March 2025, which added 67 occupational health centers, particularly in Texas.

Concentra has a long-standing reputation in workplace health, playing a significant role in establishing the current workplace health industry model since its founding in 1979. The company emphasizes its commitment to quality clinical care, evidence-based treatment best practices, and high patient satisfaction scores. There have been no specific events reported in the past year that have negatively affected Concentra Group Holdings Parent, Inc.'s brand reputation.

Concentra Group Holdings Parent, Inc. has significant institutional ownership, including T. Rowe Price Group, Inc., BlackRock, Inc., The Vanguard Group, Inc., and State Street Global Advisors, Inc. Mutual funds and ETFs hold a substantial portion of the common stock, with T. Rowe Price Mid-Cap Value Fund, Inc. and iShares Trust - iShares Core S&P Small-Cap ETF being among the top mutual fund holders. Select Medical Holdings Corporation plans to retain at least 80% of Concentra's stock following its spin-off.